CTOs on the Move

United States Renal Data System

www.usrds.org

 
United States Renal Data System is a Minneapolis, MN-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.usrds.org
  • 914 S 8th St
    Minneapolis, MN USA 55404
  • Phone: 612.347.7776

Executives

Name Title Contact Details

Similar Companies

Bay Cove Human Services

Bay Cove Human Services believes that everyone has value and offers a suite of outcome-focused services to help individuals restore their physical and mental health and develop safe, healthy, independent lives.

Gossan Resources Limited

Gossan Resources Limited is engaged in mineral exploration and development in Manitoba and northwestern Ontario. It has a well-diversified portfolio of properties hosting gold, platinum group and base metals, as well as the specialty and minor metals, vanadium, titanium, tantalum, lithium and chromium. The Company also has a large deposit of magnesium-rich high-purity dolomite. Gossan participates in the frac sand industry though an equity interest in Claim Post Resources, property payments, and a significant production royalty. The Company trades on the TSX Venture and the Frankfurt/Freiverkehr & Xetra Exchanges and has 33,170,400 common shares outstanding.

Williams Industries

Williams Industries, Inc. is a multifaceted corporation whose subsidiaries provide a wide range of quality, cost competitive services and products for the industrial, commercial and institutional construction markets. The services provided include:

Odyssey Business Services

Odyssey Business Services is a Carson City, NV-based company in the Business Services sector.

Alkeus Pharmaceuticals, Inc.

Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.